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Background: Each year the treatment and care of hundreds of millions of patients worldwide is
complicated by infections acquired during healthcare. The impact of healthcare-associated
infection may imply prolonged stays in hospital, long-term disability, massive additional financial
burden, and deaths.
Action: Patient safety is a global issue that affects both developed and developing countries. In
October 2004, theWorld Health Organization launched theWorld Alliance for Patient Safety to co-
ordinate and accelerate improvements in patient safety internationally. A core element of the
Alliance is the identification of a topic to be addressed as a Global Patient Safety Challenge over a
two-year cycle. The first topic chosen for 2005—2006 is healthcare-associated infection.
Perspectives: The Challenge aims at implementing several actions to tackle healthcare-asso-
ciated infections worldwide, regardless of the level of development of healthcare systems and
the availability of resources. Implementation strategies include the integration in different
healthcare settings of multiple interventions in the areas of blood safety, injection safety, and
clinical procedure safety, as well as water, sanitation, and waste management, with the
promotion of hand hygiene in healthcare as the cornerstone.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.§ On behalf of the World Health Organization (WHO) Global Patient
Safety Challenge (Lead, Professor D. Pittet), World Alliance for
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Patient safety is a critical component needed to improve the
quality of healthcare worldwide. Confronted with this impor-
tant issue, in 2002 the 55th World Health Assembly adopted a
resolution urging countries to pay the closest possible atten-
tion to the problem of patient safety and strengthen safety
and monitoring systems. The resolution urged the WorldPublished by Elsevier Ltd. All rights reserved.
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global norms and standards and supporting country efforts in
developing patient safety policies and practices.
In May 2004, the 57th World Health Assembly supported
the creation of an international alliance to improve patient
safety as a global initiative and the World Alliance for Patient
Safety was launched in October 2004. This event represents
the first occasion on which senior policy-makers, heads of
agencies, technical experts, and clinical and patient groups
have joined internationally to pursue the patient safety goal
of ‘Primum, non nocere’ (‘First, do no harm’) and to reduce
the adverse health and social consequences of unsafe health-
care. A core element of the World Alliance for Patient Safety
is the formulation of a Global Patient Safety Challenge. Every
two years, a topic that covers a significant aspect of risk to
patients receiving healthcare and which is relevant to every
WHO Member State will be identified for action.
The topic chosen for the first Global Patient Safety Chal-
lenge over the two-year period 2005—2006 is healthcare-
associated infection—a major, global issue in patient safety.
It occurs in developed, transitional, and developing countries
and has implications for hundreds of millions of patients
every year.
The burden of disease
Healthcare-associated infection—also referred to as nosoco-
mial infection—is defined as ‘‘An infection occurring in a
patient during the process of care in a hospital or other
healthcare facility which was not present or incubating at
the time of admission. This includes infections acquired in the
hospital but appearing after discharge, and also occupational
infections among staff of the facility’’.1,2 It clearly presents
many of the characteristics of a major patient safety problem
and has multiple causes, relating both to the systems and
processes of care provision as well as to human behavior.
Healthcare-associated infection occurs worldwide and
affects both developed and developing countries. It is esti-
mated that in developed countries 5—10%of patients admitted
toacute carehospitals acquire an infection; the attack rate for
developing countries can exceed 25%.3—6 Certain factors
increase the risk of infection among hospitalized patients:
underlying diseases and decreased immunity; the increasing
use of invasive diagnostic and therapeutic techniques; theTable 1 Examples of risk factors for the four most common hea
Urinary tract infections Surgical site infections
- Urinary catheter - Inadequate antibiotic prophylaxis
- Urinary invasive procedures - Incorrect surgical skin preparation
- Advanced age - Type of wound
- Severe underlying disease - Poor surgical asepsis
- Urolithiasis - Diabetes
- Pregnancy - Nutritional state
- Diabetes - Immunodeficiency
- Lack of training and supervision
- Suboptimal surgical site carea
a Failure of staff to cleanse hands before and after taking care of a su
wearing sterile gloves or using a non-touch technique; dressings of a clo
has signs or symptoms suggestive of infection.26transmission of drug-resistant pathogens; and poor infection
controlmeasures. However, the available studies indicate that
healthcare-associated infections are likely to be more fre-
quent and serious in developing countries where the lack of
resources and basic facilities for infection control combine
with patients being more susceptible to infection because of
malnutrition, multiple comorbidities, immunosuppression,
and poor personal hygiene. In contrast, in industrialized coun-
tries, this problem is mostly a consequence of sophisticated
and invasivehealthcare techniques combinedwithmulti-resis-
tant pathogens. In both settings, environmental factors may
play a crucial role in causing healthcare-associated infection.
Estimates of the global burden of healthcare-associated
infections are hampered by a lack of reliable data. In the
USA, the incidence is estimated at around 5—6%, with an
attributable mortality of 3.6% (40 000 to 80 000 deaths
annually) and excess costs of at least 4.5 billion US dollars
every year for the healthcare system.5 In Europe, well-
established national and international surveillance systems
are largely lacking, but studies have shown a prevalence of
healthcare-associated infections between 4.4 and 14.8%.7—18
Data on infection rates in developing countries are scarce.
Even if available, they may not be fully representative
because they are collected in hospitals with resources
exceeding the standards of the country as a whole. Multi-
center studies in Mexico, Thailand, and Brazil reported rates
of 9.0%, 11.7%, and 5.1%, respectively;19—21 however, rates
higher than 20% have been detected in some hospitals.22—25
Four types of infections account for more than 80% of all
healthcare-associated infections and are generally linked to
specific and well-known risk factors (Table 1). In developed
countries, catheter-associated urinary tract infections are
the most frequent (accounting for about 35% of healthcare-
associated infections), but carry the lowest mortality and
cost.3 Surgical site infections are second in frequency and
third in estimated cost.3,26 Bloodstream infections and pneu-
monia are less common, but are associated with much higher
mortality (up to 50%) and significant attributable mortality.3
In intensive care units (ICU), healthcare-associated infec-
tions affect about 30% of patients4,27,28 and the attributable
mortality may reach 44%.29 The relative proportions of dif-
ferent sites of infection may vary by type of ICU, but venti-
lator-associated pneumonia is generally the most
frequent.30,31 The increased risk of infection in these settingslthcare-associated infections
Lung infections Blood infections
- Mechanical ventilation - Vascular catheter
- Aspiration - Neonatal or advanced age
- Use of antidepressives - Severe underlying disease
- Antibiotics - Neutropenia
- Prolonged hospital stay - Immunodeficiency
- Malnutrition - New invasive technologies
- Advanced age - Critical care
- Nasogastric tube - Lack of training and supervision
- Surgery
- Immunodeficiency
rgical wound; staff touching an open or fresh wound directly unless
sed wound not removed or changed if they are wet or if the patient
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multiple underlying diseases, immunosuppression, advanced
age, the widespread use of invasive medical devices, crowd-
ing, and emergency situations that increase the workload and
prevent optimal implementation of infection control mea-
sures.
The solution: to achieve the Global Patient
Safety Challenge
Healthcare-associated infections are preventable. Infection
control programs can be cost-effective.32,33 More sophisti-
cated infection control measures may be required for specific
sites of infection, particular devices, or selected pathogens.
However, the most effective control measures consist of very
simple and widely-recognized precautions, such as hand
hygiene.34,35 The essential elements of an infection control
program include: healthcare worker education; a well-orga-
nized surveillance systemof healthcare-associated infections;
appropriate legislation; and consistent implementation of
basic infection control measures.
To tackle this problem, the World Alliance for Patient
Safety is implementing a multifaceted strategy and the
Global Patient Safety Challenge aims at integrating a number
of different actions to reduce healthcare-associated infec-
tion. Well-established WHO programs already address some
of the risk conditions that lead to healthcare-associated
infections in areas such as: blood products and their use;
 injection practices and immunization;
 safe water, basic sanitation, and waste management;
 clinical procedures, particularly in first-level, emergency
care.Figure 1 Actions integrated within thTheGlobal Patient Safety Challenge therefore embraces exist-
ing WHO strategies in these areas. These actions are also
combined with the new WHO Guidelines on Hand Hygiene in
Health Care (Advanced Draft) and related implementation
strategies proposed (Figure 1).
Hand hygiene
Hand hygiene, a very simple action, remains the primary
measure to reduce healthcare-associated infection and the
spread of antimicrobial resistance across all settings—from
advanced healthcare systems to local dispensaries in devel-
oping countries.34,35 However, the lack of compliance with
hand hygiene among healthcare providers is problematic
worldwide. Continuous efforts are being made to identify
effective and sustainable promotion strategies. A key action
within the Global Challenge is to promote hand hygiene in
healthcare globally as well as at country level. To provide
healthcare workers, hospital managers, and health autho-
rities with the best scientific evidence and recommendations
to improve practices and finally aim at reducing healthcare-
associated infections, WHO has developed an Advanced Draft
of the Guidelines on Hand Hygiene in Health Care.35
Pilot tests are being conducted in each of the six WHO
regions worldwide to help provide local data on the resources
required to carry out the recommendations and generate
information on feasibility, validity, reliability, and cost-effec-
tiveness of the interventions concerned. This piloting is an
essential part of the Global Patient Safety Challenge and the
process of finalizing the WHO Guidelines. It provides an
opportunity to learn practical lessons for the applicability
of the Guidelines in real field situations.
In parallel, this work in progress is accompanied by spe-
cific task forces that are addressing critical implementatione Global Patient Safety Challenge.
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of a WHO hand hygiene, alcohol-based formulation; glove use
and re-use; water quality for handwashing; education, com-
munication, and campaigning; national guidelines on hand
hygiene; and religious, cultural, and behavioral aspects of
hand hygiene.
Blood safety
Blood transfusion carries a potential risk of acute or delayed
complications and transfusion-transmitted infections. The
HIV/AIDS pandemic has focused particular attention on the
importance of preventing transfusion-transmitted infec-
tions. In 2000—2001 over 70 countries were not able to test
all donated blood for HIV, HBV, HCV, and syphilis.
The WHO Blood Transfusion Strategy supports the estab-
lishment of sustainable national blood programs in all coun-
tries that can ensure the provision of safe, high-quality blood
and blood products accessible to all patients, and their safe
and appropriate use. Key areas of focus include policies for
recruitment, selection and retention of voluntary blood
donors, blood screening, and appropriate clinical use of blood
in patient care.
The following actions to improve blood safety are inte-
grated within the Global Patient Safety Challenge: promotion of optimal hand hygiene associated with pro-
cedures for collection, processing, and use of blood pro-
ducts; promotion of donor skin antisepsis to prevent blood con-
tamination; in-service education and training on safe transfusion prac-
tices at the bedside.
Injection practices and immunization
Around 16 billion injections are administered each year in
developing and transitional countries.36 One needlestick
injury froma needle used on an infected source patient carries
an average risk of transmitting HBV, HCV, and HIVof 30%, 1.8%,
and 0.3%, respectively. In 2000, contaminated syringes caused
21.7 million hepatitis B virus infections (33% of all new infec-
tions), 2 million hepatitis C infections (40% of all new infec-
tions), and 260 000 HIV infections (5% of all new infections).36
TheWHO Injection Safety strategy works with countries to
support the formulation of national policies for the safe and
appropriate use of injections and facilitates access to safe,
high-quality injection equipment. WHO also promotes the
implementation of safe and effective systems for vaccine
delivery (i.e., accessibility of auto-disable syringes, a special
device that inactivates itself after a single use) and manage-
ment of immunization-related waste, and the establishment
and improvement of mechanisms to monitor and respond to
adverse events following immunization.
The following actions to improve injection safety are
integrated within the Global Patient Safety Challenge: promotion of optimal hand hygiene practices at time of
injection and immunization; strengthening of high-level commitment within countries
to use auto-disable syringes for immunization services; actions to ensure the safe disposal of sharps as part of an
integrated management of waste within healthcare facil-
ities.Water, basic sanitation, and waste
management
One million eight hundred thousand people die every year
from diarrheal diseases, 88% of which are attributed to
unsafe water supply and inadequate sanitation and hygiene.
Water, basic sanitation, and waste management combine to
form the safe environment needed for delivering healthcare.
Healthcare facilities require access to safe water to prevent
fecal—oral-transmitted infections and some respiratory
infections. Water quality and cleanliness are also required
to ensure effective handwashing during patient care.
Safe disposal of waste in healthcare, in particular syringe
needles or infectious body fluids, protects healthcare work-
ers and the community from infections, toxic effects, and
injuries. These apply across a range of facilities from the
reference hospital to the village health posts, residential
care accommodation, dental facilities, and home-based
care. Education and handwashing promotion can lead to
more than a 50% reduction of the disease burden and save
lives in children under 5 years of age in low-income popula-
tions.37,38
The following actions to improve water quality and avail-
ability and waste management, are integrated within the
Global Patient Safety Challenge: ensuring access and water quality to support hygiene, and
hand hygiene in particular, at the level of healthcare
facilities; ensuring sound management of waste, particularly of
highly infectious healthcare waste such as syringes and
sharps.Clinical procedures
Each year around one million people lose their lives because
of road traffic accidents. More than half a million women die
due to pregnancy-related complications. In situations such as
these, the capacity to implement correct and timely emer-
gency clinical procedures at the first referral hospital is vital.
However, in practice, the quality of surgical care is often
constrained by lack of trained staff, poor facilities, inade-
quate low technology apparatus, and limited supplies of
drugs, materials and other essentials. Without essential
surgical care, up to 10% of the population dies from injury
and 5% of pregnancies result in maternal death. In developed
countries, about 25% of healthcare-associated infections are
surgical site infections; infection rates are two- to several-
fold higher in developing countries.3
The WHO Clinical Procedures strategy is working to sup-
port countries to build capacity to reduce death and dis-
ability through strengthening the basic skills of healthcare
providers to manage essential emergency and surgical pro-
cedures at resource-limited healthcare facilities. Major
components of the strategy include supporting the devel-
opment of national policies within countries to provide basic
requirements for emergency surgical services, education
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for obstetrics, surgery and anesthesia, and development of
needs assessment and planning tools.
The following actions to improve the safety of clinical
procedures are integrated within the Global Patient Safety
Challenge: specific education programs promoting safety in surgical
procedures, tailored to the needs of healthcare facilities; surgical hand preparation using either antimicrobial soap
and water or alcohol-based hand rub to reduce infections
associated with surgical procedures; access to safe emergency and essential surgical care,
including the availability and use of best practice proto-
cols on clinical procedures and equipment.
Implementation strategies of the Global
Patient Safety Challenge
The Global Patient Safety Challenge 2005—2006 ‘Clean Care is
Safer Care’ means working worldwide to assist countries to
reduce the burden of healthcare-associated infection. The
challenges are enormous but so are the rewards: saving lives,
improving patient safety, and making life better for countless
millions of patients and their families.39 The objectives are to: raise awareness of the impact of healthcare-associated
infections on patient safety and promote preventive stra-
tegies within countries; build commitment from countries to give priority to redu-
cing healthcare-associated infections; test the implementation of the WHO Guidelines on Hand
Hygiene inHealthCare (AdvancedDraft) in specific districts
worldwide as part of an integrated package of actions
described above in the areas of clean products (blood
safety), clean practices (safe clinical procedures), clean
equipment (injection and immunization safety), and clean
environment (safe water and sanitation in healthcare).
Implementation of the Global Patient Safety Challenge in
countries is thus focused on three major strategies: aware-
ness-raising and campaigning, country pledges, and testing
implementation in districts.
Building global awareness and understanding of the impor-
tance of healthcare-associated infection will help catalyze
leadership, political commitment, and action.38 An interna-
tional awareness-raising campaign has been initiated, focus-
ing primarily on hand hygiene. National health authorities
should be at the center of efforts tominimize risks to patients
through strengthening systems, environments, processes,
and practices in the area of infection control and prevention.
WHO Member States have been invited to formally pledge to
implement actions to reduce healthcare-associated infection
within their countries and to share results and learning
internationally.
The procedure to obtain the definitive WHO Guidelines on
Hand Hygiene in Health Care includes a last, essential step:
the pilot testing phase. The different components of the
Global Patient Safety Challenge will be implemented in pilot
sites located in each of the sixWHO regions worldwide, with a
particular emphasis on the Guidelines on Hand Hygiene. Themain goals of this phase are to test the feasibility of the
Challenge overall and to learn practical lessons for the
applicability of the Guidelines in real field situations.
‘Clean Care is Safer Care’ currently focuses on short-term
objectives and available resources are currently employed to
organize regional and national events and workshops, but not
to sustain long-term programs in countries. However, human
and financial resources will be allocated to support pilot sites
where the WHO Guidelines on Hand Hygiene in Health Care
are being tested along with the implementation of other
interventions related to blood, injection, clinical procedure,
and water and environmental safety. The final, recom-
mended strategy will then be tailored according to lessons
learned on feasibility and local acceptability. Finally, the aim
is also to produce a set of practical, validated tools that are
easily available and free of charge to both resource-poor and
resource-rich countries or institutions that are interested in
promoting hand hygiene in healthcare.
Conclusion
Safety is a fundamental principle of patient care and a
critical component of quality management. Its improvement
demands a complex system-wide effort involving a broad
range of actions related to performance improvement, envir-
onmental safety, and risk management, including infection
control, safe use of medicines, equipment safety, safe clin-
ical practice, and a safe care environment.
Healthcare-associated infection is of paramount impor-
tance worldwide; it affects the quality of care and patient
safety and adds tremendous and needless costs to healthcare.
The commitment of the World Alliance for Patient Safety
to reduce healthcare-associated infections by selecting this
topic as the first Challenge is an unprecedented step. The
combined efforts expected under the Global Patient Safety
Challenge have the potential to save millions of lives and
release major resource savings by improvement of basic
procedures and a greater adherence paid to hand hygiene
protocols among healthcare providers.
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